Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of asparaginase and methotrexate metabolism in childhood acute lymphoblastic leukemia
NL-OMON44473Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of pegaspargase and methotrexate in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Erasmus MC. Primary endpoints: PEGaspargase clearance, Inter-patient variability in clearance and 6 more. Started Mar 2015; status: active, not recruiting.
02
Drugs
pegaspargasemethotrexate
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON44473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44473.